International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 491-497 doi: 10.5281/zenodo.16789980
Original Article
Diagnostic Accuracy and Inter-Score Agreement Between BISAP and Ranson’s Scoring Systems in Predicting Severity of Acute Pancreatitis: A Cross-Sectional Study
 ,
 ,
 ,
Published
Aug. 10, 2025
Abstract

Background: Early prediction of severity in acute pancreatitis (AP) is essential for timely intervention and resource allocation. The Ranson scoring system is widely used but requires 48-hour data, whereas the BISAP score offers a simplified and earlier alternative.

Objective: To compare the diagnostic accuracy and inter-score agreement between BISAP and Ranson scoring systems in predicting the severity of acute pancreatitis.

Methods: A prospective observational study was conducted over two years on 50 patients with acute pancreatitis at a tertiary care hospital. Severity was classified using both BISAP (within 24 hours) and Ranson (over 48 hours) scores. Outcomes including ICU admission, length of hospital stay, and mortality were recorded. Sensitivity, specificity, predictive values, and agreement between scores were analyzed using standard statistical methods.

Results: Out of 50 patients, Ranson score identified 8 (16%) as having severe AP, while BISAP identified 7 (14%) as severe. The sensitivity and specificity of BISAP in comparison to Ranson were 87.5% and 100%, respectively. The positive predictive value was 100%, and the negative predictive value was 97.67%. BISAP showed strong agreement with Ranson scoring in severity classification.

Conclusion: BISAP is a simple, early, and reliable tool for predicting severity in acute pancreatitis. Its comparable accuracy to Ranson scoring, combined with ease of bedside application, supports its use as a practical alternative for early triage and risk stratification in emergency and resource-constrained settings

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
83 Views
183 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved